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Reversible Epigenetic Modifications
of the Two Cardiac Myosin Heavy Chain
Genes During Changes in Expression
KUMAR PANDYA,* BENJAMIN PULLI,* SCOTT BULTMAN,† AND OLIVER SMITHIES*
*Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill,
Chapel Hill, NC, USA
†Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
The two genes of the cardiac myosin heavy chain (MHC) locus—alpha-MHC (aMHC) and beta-MHC
(bMHC)—are reciprocally regulated in the mouse ventricle during development and in adult conditions such as
hypothyroidism and pathological cardiac hypertrophy. Their expressions are under the control of thyroid hor-
mone T3 levels. To gain insights into the epigenetic mechanisms that underlie this inducible and reversible
switching of the aMHC and bMHC isoforms, we have investigated the histone modification patterns that occur
over the two cardiac MHC promoters during T3-mediated reversible switching of gene expression. Mice fed a
diet of propylthiouracil (PTU, an inhibitor of T3 synthesis) for 2 weeks dramatically reduce aMHC mRNA
expression and increase bMHC mRNA levels to high levels, while a subsequent withdrawal of PTU diet for 2
weeks completely reverses the T3-mediated changes in MHC expression. Using hearts from mice treated in this
way, we carried out chromatin immunoprecipitation-qPCR assays with antibodies against acetylated histone H3
(H3ac) and trimethylated histone (H3K4me3)—two well-documented markers of activation. Our results show
that the reexpression of bMHC is associated at the bMHC promoter with increased H3ac but not H3K4me3. In
contrast, the silencing of aMHC is associated at its promoter with decreased H3K4me3, but not decreased H3ac.
The epigenetic changes at the two MHC promoters are completely reversed when the gene expression returns to
initial levels. These data indicate that during reciprocal and inducible gene expression H3ac parallels bMHC
isoform expression while H3K4me3 parallels expression of the tightly linked aMHC isoform.
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INTRODUCTION isoform in the fetal ventricle. It is expressed from
E8.5 until around birth, at which time its expression
is reduced to very low levels. aMHC is the main iso-Myosin heavy chain (MHC) proteins are important
enzymatic components of the thick filaments of the form in the adult murine ventricle. Its expression is
very low in the fetal ventricle and is increased aroundsarcomere—the fundamental unit of contraction in a
muscle cell—and their intrinsic ATPase activity is birth so that aMHC becomes the major isoform by
neonatal day 8. During conditions of heart failure,responsible for transducing chemical energy into me-
chanical energy [reviewed in (31)]. The two MHC hypothyroidism, and aging, expression of the two iso-
forms is reversed, so that bMHC is reexpressed inisoforms in the cardiac ventricle, alpha-MHC (aMHC)
and beta-MHC (bMHC), are normally expressed in the cardiac myocytes while aMHC is downregulated
[reviewed in (21)].a developmental stage-specific manner in the mouse
ventricle [reviewed in (32)]. bMHC is the main MHC Expression of the two MHC genes is under the
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control of the thyroid hormone (T3), and the switch and heart failure (6–8,10,11,28,29). However, the
epigenetic control of the two MHCs genes has notin expression from bMHC to aMHC that occurs
around birth is due to a surge in T3 production. De- been studied. Thus, it unclear what specific histone
modifications are associated with the two MHCcreasing the levels of T3 in the adult (e.g., by surgical
thyroidectomy or chemical inhibition of T3 synthesis) genes. It is also not clear whether the histone modifi-
cations are changed when expression of the genes isreverses the expression levels of the two MHCs. T3
binds to thyroid hormone receptor (THR), a nonste- altered. Consequently, we have investigated the changes
in two histone modifications of the two cardiac MHCroidal nuclear hormone receptor [reviewed in (2)].
THR binds to its recognition sites, thyroid responsive genes when their expression is altered by changes in
T3 levels. We show that H3K4me3 histone methyla-elements (TRE), independently of the presence or ab-
sence of its ligand, T3. Whether the ligand(s) silences tion accompanies the changes in aMHC expression
while H3 histone acetylation accompanies the changesor activates the downstream gene depends on the type
of TRE. Genes with positive TRE (pTRE) are acti- in bMHC expression when expression of the two
genes is changed reversibly in either direction by thevated by T3, while genes with negative TRE (nTRE)
are silenced by T3. bMHC has a negative TRE at its presence or absence of T3.
promoter, and the presence of T3 consequently si-
lences expression of bMHC. In contrast, aMHC has
a positive TRE at its promoter, and presence of T3
MATERIALS AND METHODSactivates expression while absence silences expres-
sion of aMHC. Animals
The amino terminal tails of histones are the target
Animals used in this study were 4-month-oldof multiple posttranslational modifications: acetyla-
C57blk6/J. Animals were fed an iodine-deficient diettion, methylation, phosphorylation, and ubiquitylation
containing 0.15% propylthiouracil (PTU) (Harlan(15). During the past decade, the functional impact of
Teklad, TD. 97061, Rx257896) for 2 weeks, and thencovalent histone modifications on gene regulation has
either sacrificed (PTU group) or fed normal chow forbeen unequivocally demonstrated (17,33). Multiple stud-
another 2 weeks (reversal). Control mice were fedies have revealed correlations between histone modi-
normal chow. The mice were maintained in a facilityfications and gene expression (1,9,20,30). The pres-
accredited by the Association for the Assessment andence of acetylated lysine residues in histone H3
Accreditation of Laboratory Animal Care Interna-(H3ac) is associated only with active genes. Although
tional according to Institutional Animal Care and Usehistone methylation can be associated with either ac-
Committee-approved guidelines.tive or repressed genes, trimethylation of lysine 4 of
histone 3 (H3K4me3) is only associated with active
genes (1,3). Thus, H3ac and H3K4me3 are two post- Tissue and Chromatin Isolation
translational modifications whose presence or ab-
sence are important indicators of gene expression. Hearts were surgically isolated and ventricles sepa-
rated from atria. Ventricles were frozen in liquid ni-The MHC genes provide an excellent model sys-
tem for studying gene regulation, because they are trogen and pulverized using a mortar and pestle. The
pulverized tissue was cross-linked by resuspending inreciprocally regulated in a tissue and developmental
stage specific manner. Furthermore, they are both 10 ml of warm 1% formaldehyde and rotated at room
temperature for 10 min. Cross-linking was stoppedcontrolled by the same hormone (T3) and can be in-
duced to dramatically change their expression levels by the addition of 1260 µl of 1 M glycine. Tissue
was pelleted at 1000 × g for 5 min at 4°C, andin a reversible manner in the adult heart. The two
genes are close together in the genome, with bMHC washed with 5 ml cold PBS. Tissue from a single
heart was resuspended in 5 ml of Farnham lysisbeing located 5′ to aMHC and separated by a 4.5-kb
intergenic region, which includes the aMHC pro- buffer (5 mM PIPES, 85 mM KCl, 0.5% NP-40) with
freshly added protease inhibitors (Roche Diagnostics,moter. Several studies have uncovered important cis-
acting regulatory elements and trans-acting factors Cat. #14696200) and incubated for 30 min on ice.
The tissue was then dounce homogenized (10that are responsible for their expression, such as
NFAT, MEF2, MCAT for bMHC [reviewed in (21)] strokes) and pelleted at 1000 × g for 5 min at 4°C.
The pellets were resuspended in SDS buffer (1%and Ku and Yin Yang for aMHC (19,26). Recent
studies have also implicated antisense- and micro- SDS, 10 mM EDTA, 50 mM Tris) at 30 mg of heart
tissue/ml of SDS buffer and incubated for 5 min onRNA-mediated mechanisms as playing a role in the
control of MHC gene expression during development ice and stored at −80°C.
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Chromatin Immunoprecipitation (ChIP) Assay switch the expression of aMHC and bMHC in the
adult mouse heart (24). Accordingly, 4-month-old
Each ChIP assay was carried out on chromatin iso-
C57BLK6/J mice were fed an iodine-free diet con-
lated from 3 mg equivalent of heart tissue. Sonication
taining 0.15% PTU for 2 weeks. To confirm that this
conditions were empirically determined (8 × 30-s
PTU treatment changed the expression levels of the
pulses with 30 s cooling between pulses) using a
two MHC we conducted real time-qPCR on the heart
Branson Sonicator at 30% power to give 200–800-bp
tissue from control and PTU-treated mice. Figure 1
fragments, with a peak at 500 bp. After sonication,
depicts the mRNA expression levels of aMHC (Fig.
chromatin was spun 14,000 rpm for 15 min at 4°C.
1A) and bMHC (Fig. 1B) in the hearts of PTU-treated
Five percent of chromatin was removed (5% input)
animals (closed bars) and untreated animals (open
and the remaining chromatin submitted to immuno-
bars). As illustrated in the figure, PTU treatment has
precipitation procedure exactly as described pre-
a dramatic effect on the expression levels of the two
viously (4). Ten micrograms of either pan-acetylated
MHC: aMHC, which is typically expressed at high
histone H3 (Millipore, Cat. #06-599) or H3K4me3
levels, is significantly reduced (approximately 300-
(abcam, Cat. #ab8898) antibodies were used for im-
fold relative to untreated animals, p < 0.0001); bMHC,
munoprecipitation. Mock IPs were carried out in par-
which is typically expressed at low levels, is dramati-
allel but without using any antibody. Values for mock
cally increased (approximately 50-fold relative to un-
IPs were 5–10-fold lower than test IPs.
treated animals, p < 0.001). Thus, the expression lev-
els of the two MHC genes are dramatically altered in
qPCR
opposite directions, thereby allowing a close to ideal
model system in which to study the changes in epige-Purified chromatin from each IP was resuspended
in 25 µl of water, and qPCR carried out on 1 µl puri- netic modifications occurring at two genes of the same
locus.fied DNA using SYBR green and real-time PCR pro-
cedure. The qPCR data were calculated using ddCT
method relative to the sample representing 5% input, PTU Treatment Changes H3ac at bMHC But Not
which was tested simultaneously on the same plate. at aMHC
Fold enrichment relative to 100% input was calcu-
lated by dividing the fold enrichment (relative to 5%) Because acetylation of histone H3 has been dem-
onstrated to be an important marker for active geneinput by 20. Six independent ChIPs (2 ChIPs/heart
and 3 hearts/condition) were conducted for each con- expression, we first investigated the H3ac levels in
the promoters and 5′ regions of the two MHC genes.dition (control, PTU, and reverse) for histone acetyla-
tion. H3k4me3 ChIP-qPCRs involved a total of seven We conducted ChIP assays on whole heart tissue us-
ing a pan-acetyl histone H3 antibody that recognizesindependent ChIPs from four animals for each condi-
tion. Data are presented as mean ± SEM for each data acetylated lysine 9 and acetylated lysine 14 of histone
H3. This antibody has been used extensively by oth-point. The p-values were calculated using Student t-
test between control and PTU groups (denoted by *) ers to test H3 lysine acetylations, hereafter referred
to as H3ac. We used quantitative real-time PCRor between PTU and reversal groups (denoted by #).
Primer sets were designed at the designated position (qPCR) to quantify the enrichment of acetylated his-
tone H3 at multiple locations of the two MHC genes.on the bMHC and aMHC genes to give 100–120-
bp products. Each primer set was tested against geno- Figure 2 illustrates the locations of the primer pairs
used for qPCR analyses at the bMHC and aMHCmic DNA for product specificity and purity. The
primer sequences used are shown in Table 1. Gene genes. Histone acetylations were assessed at seven
individual locations for bMHC: −5 kb, −3 kb, −1 kb,expression for bMHC and aMHC was conducted as
described previously (22,23). −0.5 kb, 0 kb, +3 kb, and +5 kb, and six individual
locations for aMHC: −3 kb, −1 kb, −0.5 kb, 0 kb, +3
kb, and +5 kb, each relative to its transcription start
site at 0 kb.RESULTS
The results of the ChIP qPCRs for bMHC using
PTU Treatment Changes the Expression of the Two
the pan-acetylated histone H3 (H3ac) are depicted in
MHC Genes in Reverse Direction
Figure 3. Hearts from untreated animals (open cir-
cles) show levels of H3ac that are similar at all loca-The expression of aMHC and bMHC in the mouse
heart is dependent on the actions of thyroid hormone tions within the bMHC gene. Hearts from animals
treated with PTU (Fig. 3, open squares) show in-T3. PTU is an inhibitor of the terminal step of T3
synthesis, and has been previously demonstrated to creased levels of H3ac at multiple locations within
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bMHC −5.0 kb 5′-TAAGTCCAATATTAGAGATTCCAATTGAAGAT-3′ 5′-GGTGTGGGGGAGCTGGCTTTTAG-3′
bMHC −3.0 kb 5′-GGAGCAGCTGCTTGTTAAAGAGAAACC-3′ 5′-GGAGTGGTAGCCAGCACTTGCCCC-3′
bMHC −1.0 kb 5′-CTAGGAAGAACAAAGATTGCACCCACG-3′ 5′-CCTGCAGATTTTCGAGGCGCAAGG-3′
bMHC −0.5 kb 5′-CCAACTCTGCCCTGCCCCTCT-3′ 5′-TTGCCCCCAGTGCTAGCCTGG-3′
bMHC 0 kb 5′-AAATCTGGCTAGGGACTGG-3′ 5′-CCTACCTGAGGGTAGCAAGTA-3′
bMHC +3 kb 5′-CCCTGATCCCAGAATCCCCTGAGA-3′ 5′-GGGAGAGAGGCACAAAGAAAAGAGTTG-3′
bMHC +5 kb 5′-GGAGAGCCCTACAGACCCTGGG-3′ 5′-CTCTGTAGCTGCTGTGGGCTACC-3′
aMHC −3.0 kb 5′-CCCAAGCTGACCCAATGTTCTCAGTA-3′ 5′-GGCCACCTGTCTGCAGCTGTGT-3′
aMHC −1.0 kb 5′-CACCCACACCAGACCTCTCCC-3′ 5′-CCTCCTGCCACTGAGAACTTCCCA-3′
aMHC −0.5 kb 5′-GAGTGCTGAGAATCACACCTGGGG-3′ 5′-ATGGAACAGGACAAGCCAGGG-3′
aMHC 0 kb 5′-CTCCAAATTTAGGCAGCAG-3′ 5′-CGAAACTCCCTCTTACCTG-3′
aMHC +3.0 kb 5′-TGCAGGCATACACAGATAAACAGACAC-3′ 5′-GGCCTTTGTCCCTCAAACATGACT-3′
aMHC +5.0 kb 5′-CAAAGGAATGGAGGTACTGAAAATGCTT-3′ 5′-CCACCTTCACCCGAGGGTGACA-3′
the bMHC gene, with the levels reaching significance Thus, changes in H3K4me3 levels do not follow the
changes in expression of the bMHC gene.at −1 kb (p < 0.005), +3 kb (p < 0.01), and +5 kb
(p < 0.05) positions. These increases in the pan- To test if this modification is altered at the aMHC,
we conducted qPCRs for the different aMHC loca-acetylation levels of histone H3 at the bMHC gene
during PTU treatment, which results in increased lev- tions on the same ChIP/H3K4me3 samples as were
used for bMHC experiments. Figure 6 illustrates theels of expression, are consistent with the role of H3
acetylation as a marker of active gene expression. results of qPCR on the aMHC promoter for untreated
hearts (open circles) and PTU-treated hearts (openWe next investigated the changes in H3ac levels at
the aMHC in the same samples. Figure 4 illustrates squares). The data show substantial decreases in the
H3K4me3 levels at multiple locations with the de-the results of the ChIP qPCRs done on the hearts
from untreated (open circles) and PTU-treated (open creases reaching significance at +3 kb (p < 0.05) and
+5 kb (p < 0.05). This decrease in H3K4me3 modifi-squares) animals at multiple locations within aMHC
promoter. Strikingly, no significant changes were cation in the PTU-treated hearts is concordant with
the substantial decrease in aMHC gene expression.found in the H3ac levels at any location between the
control and PTU-treated animals, even though PTU Together, our data show that, in response to PTU
treatment, histone H3K4me3 levels are substantiallytreatment decreased the expression of aMHC by al-
most 300-fold. These data show that H3ac levels changed at aMHC but not at bMHC, even though the
expression levels of both genes change dramatically.change only at the bMHC gene, but not the aMHC
gene, in response to PTU treatment, even though the
PTU-Induced Changes Are Completely Reversibleexpression levels of both genes show dramatic
at Each MHCchanges in gene expression.
To test whether the epigenetic changes at the two
PTU Treatment Changes H3K4me3 at aMHC
MHC genes could be reverted to their original states
But Not bMHC
when the gene expression changes are reversed, ani-
mals previously treated with PTU for 2 weeks (solidTo test if the two MHC genes show discordant
changes with respect to other epigenetic markers, we black bars in Fig. 1) were returned to a diet of regular
chow for a further 2 weeks (cross-hatched bars innext considered H3K4me3. Genome-wide studies have
shown that H3K4me3 is a widespread marker of ac- Fig. 1). The data show that the expression of aMHC
in the hearts from these animals is restored to a hightive gene expression (1,3). We conducted ChIP qPCR
analyses on the hearts from the same two groups de- level indistinguishable from that of the untreated con-
trol animals (p = 0.8 for reversal verses untreated),scribed above using an antibody to H3K4me3. Figure
5 depicts the levels of H3K4me3 at multiple locations while the expression of bMHC is restored to a low
level indistinguishable from that of the untreated con-of bMHC gene in the hearts of control (open circles)
and PTU-treated (open squares). No differences were trol animals (p = 0.7 for reversal verses untreated).
Thus, withdrawal of the PTU treatment for 2 weeksfound in the levels of H3K4me3 between the control
and PTU-treated hearts at the bMHC promoter, al- completely restores the expression profile of aMHC
and bMHC back to control levels.though bMHC expression and the levels of H3ac
were significantly increased in the same samples. ChIP qPCR analyses were conducted on chromatin
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isolated from these hearts using antibodies against creases of H3ac at bMHC and decreases in H3K4me3
at aMHC are completely reversible.H3ac and H3K4me3. Figure 3 shows that the PTU-
induced increases in H3ac levels at the bMHC pro-
moter are reduced back to levels that are indistin-
guishable from untreated levels (compare open squares DISCUSSION
with closed squares), in parallel with the decrease in
expression of bMHC. Similarly, withdrawal of PTU Changes in histone modification have been recog-
nized as being intricately associated with gene regu-increases H3K4me3 levels at the aMHC promoter
back to levels indistinguishable from untreated levels lation for over 10 years (9,15,17,20,33). The two
most conserved markers of gene activation are in-(Fig. 6, compare open squares with closed squares),
in parallel with the increases in expression of aMHC. creased acetylation of multiple lysine residues and in-
creased trimethylation of lysine 4 of histone H3.In contrast, histone acetylation and H3K4me3 levels
remain unchanged at the aMHC and bMHC, respec- There is, however, much less documentation of the
plasticity of these modifications in the face of revers-tively (Figs. 4 and 5, compare open squares with
closed squares), even though the PTU withdrawal ible gene expression. Thus, although it is clear that
gene activation is correlated with increases in the lev-substantially changed the expression of these genes.
Together, these data show that PTU-induced in- els of these modifications, it is not clear to what de-
gree these active modifications are lost when gene
expression is subsequently silenced. The MHC locus
is an excellent model system for studying inducible
expression of reciprocally regulated genes, because
the same stimulus (T3) dramatically regulates the ex-
pression of the two MHC genes in opposite direc-
tions. In this report we analyze the changes in the
levels of histone acetylation (H3ac) and H3K4me3 at
multiple sites within the promoters of the cardiac
aMHC and bMHC genes.
We first used PTU-based inhibition of thyroid hor-
mone synthesis to induce reversible changes in the
expression of the aMHC and bMHC in the heart.
Mice fed a PTU diet for 2 weeks dramatically reduce
their expression of aMHC by about 300-fold and in-
crease bMHC expression about 50-fold. Subsequent
replacement of the PTU diet with normal chow for 2
weeks results in a complete return of the gene expres-
sion levels of aMHC and bMHC to their initial levels.
These dramatic and reversible changes in expression
of two linked genes in response to the same stimulus
provided us with an excellent model system with
which to investigate reversible shifts in epigenetic
modifications during gene expression.
The change in expression of aMHC in response to
T3 is an example of a pTRE form of regulation. THR
constitutively binds to TRE sequences in promoters
and, in the absence of T3, represses expression of the
downstream gene (5), acting through a co-repressor
complex that is formed in the absence of TH. This
Figure 1. Reversible changes in mRNA expression levels of MHCs
co-repressor complex consists of NCoR/SMRT pro-in response to PTU treatment. Comparisons of mRNA expressions
relative to the mean of untreated animals (Relative Expression) for teins that recruit a complex of histone deacetylases
(A) aMHC, and (B) bMHC from hearts of untreated (white bars), (including HDAC1, HDAC2, HDAC3, HDAC4,
PTU-treated (black bars), and PTU withdrawal (reversal, gray
HDAC5, HDAC7, HDAC9) that deacetylate the his-bars) animals. The mean for untreated group was set at 1, and the
values for other groups are relative to this value. Animals were fed tones surrounding a responding gene, resulting in its
either regular chow (untreated), PTU diet for 2 weeks (PTU), or repression (14). The THR-mediated repression in the
PTU diet for 2 weeks followed by regular chow for a further 2
absence of TH is also associated with decreases inweeks (reversal), and hearts isolated for analyses. Quantitative
gene expressions were determined by Taqman real-time PCR. the levels of histone methylation including H3K4me3
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Figure 2. Locations of the primers used for ChIP qPCRs. Schematic of primer pairs (each arrowhead denotes a single primer) for multiple
locations at the bMHC (A) and aMHC (B). Location nomenclature is relative to the transcription start site (0 kb). Boxes represent exons.
Each primer pair amplified a fragment of approximately 100 to 120 bp.
(18). Binding of TH to THR induces a conforma-
tional change that causes the dissociation of the co-
repressor complex, and recruitment of co-activator
complex that includes p160/steroid receptor proteins,
Figure 3. ChIP qPCRs analyses for pan-acetylation of histone H3
at the bMHC gene. Percent enrichment (relative to 100% input) of
immunoprecipitated DNA is shown on the y-axis and the various
locations of bMHC are shown on the x-axis. ChIP PCRs were con- Figure 4. ChIP qPCRs analyses for pan-acetylation of histone H3
at the aMHC gene. Percent enrichment (relative to 100% input) ofducted using anti-pan-acetylated H3 antibody (recognizing acetyl-
ated lysines 9 and 14) from chromatin isolated from untreated immunoprecipitated DNA is shown on the y-axis and the various
locations of aMHC are shown on x-axis. ChIP PCRs were con-(open circles), PTU-treated (open squares), or reversal (closed
squares) animals. Each data point represents mean of six indepen- ducted using anti-pan-acetylated histone h3 antibody (recognizing
acetylated lysines 9 and 14) from chromatin isolated from un-dent ChIP experiments from three individual animals within each
group. Error bars represent SEM. *p < 0.05 (relative to untreated treated (open circles), PTU-treated (open squares), or reversal
(closed squares) animals. Each data point represents the mean ofgroup), **p < 0.01 (relative to untreated group), ***p < 0.005
(relative to untreated group), #p < 0.05 (relative to PTU group), six independent ChIP experiments from three individual animals
within each group. Error bars represent SEM.##p < 0.01 (relative to PTU group).
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HAT activity that increases the acetylation of lysine
residues on the histones. Our ChIP qPCR analyses
show that the 300-fold decrease in expression of
aMHC is associated with highly significant decreases
in the levels of H3K4me3 at the aMHC promoter.
Surprisingly, however, this decrease in expression of
aMHC is not associated with changes in levels of his-
tone h3 acetylation, because ChIP qPCR analyses
done on the same samples show no differences in the
levels of histone acetylation at the aMHC gene. Thus,
PTU-mediated changes in aMHC gene expression are
associated with changes in H3K4me3 levels but not
in H3ac levels showing that histone H3ac is not
obligatory for TH-mediated activation of pTRE-asso-
ciated gene activation.
The response of bMHC to T3 is an example of a
Figure 5. ChIP qPCRs analyses for H3K4me3 at the bMHC gene. nTRE form of regulation (2). Thus, in the absence of
Percent enrichment (relative to 100% input) of immunoprecipitated
T3, the THR binds to the TRE site of bMHC andDNA is shown on the y-axis and the various locations of bMHC
activates its transcription. In the presence of T3, theare shown on the x-axis. ChIP PCRs were conducted using anti-
H3K4me3 antibody from chromatin isolated from untreated (open receptor becomes a repressor, presumably via the loss
circles), PTU-treated (open squares), or reversal (closed squares)
of co-activators and concomitant recruitment of co-animals. Each data point represents mean of seven independent
repressors. We find that treatment with PTU in-ChIP experiments from four individual animals within each group.
Error bars represent SEM. creases the expression of bMHC approximately 50-
fold, and that this increase in expression of bMHC
is associated with increases in histone acetylation at
p300, and TRAP/DRIP, which together directly re- multiple sites within the bMHC promoter. These ob-
cruits the RNA Pol II and other members of the basal servations are consistent with previous reports impli-
transcriptional machinery and leads to the formation cating increases in histone acetylation in other nTRE-
of preinitiation complex and to transcriptional activa- mediated increases in gene expression. For example,
tion (13,16). Many of these proteins have intrinsic it has been demonstrated that the co-repressors
NCoR/SMRT/SRC associate with the histone deace-
tylase HDAC1 and HDAC2, leading to decreases in
histone acetylation levels at the promoters of thyroid-
stimulating hormone and thyrotropin-releasing hor-
mone (12,25,27). Consistently, the activation of these
genes in the presence of T3 leads to the dissociation
of HDAC2/HDAC3. Surprisingly, however, little is
known, regarding the identity of the HATs that are
responsible for the ligand-mediated increases in the
acetylation of nTRE genes. There is one report dem-
onstrating that T3-dependent repression of a nTRE
gene is associated with decreases in H3K4me3 (27).
However, our data show that T3-mediated changes in
bMHC expression are not associated with changes in
H3K4me3. Thus, decreases in H3K4me3 are not
obligatory for T3 regulation of all nTRE-responsive
genes.
Figure 6. ChIP qPCRs analyses for H3K4me3 at the aMHC gene.
Our data also demonstrate that the changes in his-Percent enrichment (relative to 100% input) of immunoprecipitated
DNA is shown on the y-axis and the various locations of aMHC tone modifications induced by PTU are completely
are shown on the x-axis. ChIP PCRs were conducted using anti- reversible at both MHC when the PTU is withdrawn,
H3K4me3 antibody from chromatin isolated from untreated (open
as are the corresponding changes in gene expression.circles), PTU-treated (open squares), or reversal (closed squares)
animals. Each data point represents mean of seven independent Thus, the PTU-induced increase in histone acetyla-
ChIP experiments from four individual animals within each group. tion at the bMHC promoter is completely reversed
Error bars represent SEM. *p < 0.05 (relative to untreated group),
when the animals are returned to a normal diet for 2#p < 0.05 (relative to PTU group), ##p < 0.01 (relative to PTU
group), ###p < 0.005 (relative to PTU group). weeks. Similarly, the decrease in histone methylation
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induced at the aMHC promoter by PTU treatment is one other active promoter has been identified that
does not show both modifications simultaneously: thecompletely restored to the higher initial levels after
PTU withdrawal. It is important to note that in car- promoter of gamma inferferon in T cells has high
levels of H3K4me3 but not of H3ac (both K9 anddiac myocytes, which do not divide appreciably in
the adult, any decreases in histone modification lev- K14) (30). Thus, joint occurrences of these two mod-
ifications are not universally associated with gene ac-els must be the result of active removal of the modifi-
cations rather than dilution by new unmodified his- tivation even with two reciprocally expressed tightly
linked isoforms.tones synthesis during cell replication. The identity
of the different HDACs and demethylases involved In summary, we show that the T3-responsive
changes in aMHC and bMHC gene expression in thein bMHC and aMHC silencing, respectively, is not
known, and further work needs to done to identify adult murine heart involve reversible histone modifi-
cations at the promoter, with H3ac accompanyingthe temporal steps in MHC gene regulation.
Genome-wide studies have demonstrated that the changes in expression of the bMHC isoform, and
H3K4me3 accompanying changes in the tightlypromoters of active genes are generally associated
with increased levels of both H3 acetylation as well linked aMHC isoform.
as with increased trimethylation of H3K4. However,
our data showing that the increase in H3ac occur only
ACKNOWLEDGMENTSat bMHC while the increase in h3K4me3 occurs only
at aMHC demonstrated that these two posttransla- This work was supported by grants from NIH
[HL49277 (O. Smithies) and CA125237 (S. Bult-tional modifications are not both required for expres-
sion of the two closely linked MHC genes. At least man)].
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